IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 24.622
NA - Nord America 16.264
EU - Europa 5.102
SA - Sud America 2.356
AF - Africa 242
Continente sconosciuto - Info sul continente non disponibili 140
OC - Oceania 75
AN - Antartide 3
Totale 48.804
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.565
SG - Singapore 15.487
CN - Cina 3.748
HK - Hong Kong 3.026
IT - Italia 2.443
BR - Brasile 1.571
GB - Regno Unito 912
VN - Vietnam 826
FR - Francia 665
BD - Bangladesh 320
IN - India 316
CA - Canada 311
DE - Germania 295
AR - Argentina 243
MX - Messico 197
CO - Colombia 178
ID - Indonesia 158
EC - Ecuador 146
NL - Olanda 116
ZA - Sudafrica 97
TR - Turchia 94
JP - Giappone 83
FI - Finlandia 76
UA - Ucraina 73
AU - Australia 68
VE - Venezuela 68
PL - Polonia 65
SA - Arabia Saudita 65
ES - Italia 62
RU - Federazione Russa 60
PH - Filippine 59
MY - Malesia 53
IQ - Iraq 51
PY - Paraguay 51
PK - Pakistan 48
CL - Cile 41
SE - Svezia 37
CZ - Repubblica Ceca 35
EE - Estonia 34
JM - Giamaica 34
CR - Costa Rica 32
PE - Perù 32
UZ - Uzbekistan 32
MD - Moldavia 31
MA - Marocco 25
TH - Thailandia 25
HN - Honduras 22
NP - Nepal 22
BE - Belgio 21
EG - Egitto 21
CH - Svizzera 19
LT - Lituania 19
GT - Guatemala 18
KR - Corea 18
AZ - Azerbaigian 17
AE - Emirati Arabi Uniti 16
UY - Uruguay 16
DO - Repubblica Dominicana 15
NI - Nicaragua 15
DZ - Algeria 14
KZ - Kazakistan 14
ET - Etiopia 13
AT - Austria 11
IL - Israele 11
JO - Giordania 11
KG - Kirghizistan 11
PT - Portogallo 11
RO - Romania 11
TN - Tunisia 11
AL - Albania 10
BH - Bahrain 10
KE - Kenya 10
RS - Serbia 10
SI - Slovenia 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
TW - Taiwan 10
GR - Grecia 9
KW - Kuwait 9
OM - Oman 9
BA - Bosnia-Erzegovina 8
HU - Ungheria 8
IE - Irlanda 8
PS - Palestinian Territory 8
SY - Repubblica araba siriana 8
BG - Bulgaria 7
BO - Bolivia 7
KH - Cambogia 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
BY - Bielorussia 6
CY - Cipro 6
LB - Libano 6
AM - Armenia 5
DK - Danimarca 5
LA - Repubblica Popolare Democratica del Laos 5
QA - Qatar 5
XK - ???statistics.table.value.countryCode.XK??? 5
BS - Bahamas 4
DM - Dominica 4
Totale 48.544
Salva come PNG Salva come JPEG
Città #
San Jose 3.893
Ashburn 3.419
Hong Kong 3.004
Singapore 2.367
Rome 1.669
Hefei 1.390
Council Bluffs 864
Boardman 803
Beijing 750
Columbus 708
London 675
Lauterbourg 593
Shanghai 489
Dallas 472
Santa Clara 374
Ho Chi Minh City 278
Los Angeles 218
New York 203
Hanoi 184
Phoenix 183
San Francisco 170
São Paulo 149
Seattle 111
Toronto 109
Pune 107
Munich 95
Mexico City 94
Washington 73
Chicago 71
Tokyo 63
Brooklyn 59
Milan 58
Bogotá 57
Rio de Janeiro 57
Atlanta 55
Warsaw 55
Amsterdam 51
Orem 50
Montreal 49
Guayaquil 48
Quito 47
Brasília 43
Johannesburg 43
Naples 43
Denver 42
Buffalo 40
Chennai 40
Frankfurt am Main 40
Philadelphia 40
Turku 40
Las Vegas 39
Boston 37
Haiphong 36
Da Nang 35
Helsinki 35
Melbourne 34
Tashkent 30
Belo Horizonte 29
Brno 29
Riyadh 28
Thái Bình 28
Biên Hòa 27
Kingston 27
Stockholm 27
San José 26
Jeddah 24
Medellín 24
Buenos Aires 23
Hangzhou 23
Manchester 23
Miami 23
New Delhi 23
St Louis 23
Asunción 22
Charlotte 22
Porto Alegre 22
Baghdad 21
Florence 21
Kuala Lumpur 21
Lima 21
Ribeirão Preto 21
Curitiba 20
Secaucus 20
The Dalles 20
Bologna 19
Istanbul 19
Palermo 19
Cleveland 18
Houston 18
Campinas 17
Jacksonville 17
Jakarta 17
Ankara 16
Canberra 16
Dhaka 16
Joinville 16
Ninh Bình 16
Salvador 16
Sydney 16
The Bronx 16
Totale 25.691
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 288
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 272
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 266
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 266
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 258
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 257
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 254
Early impairment of food intake in patients newly diagnosed with cancer 247
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 244
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 243
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 242
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 241
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 241
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 241
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 240
Designing a broad-spectrum integrative approach for cancer prevention and treatment 240
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 239
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 239
A key opinion leader interview with Prof D Santini: insight into cancer research. 237
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 235
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 235
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 233
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 232
Prevention of radiotherapy-induced emesis 229
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 228
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 228
Premetastatic niche: ready for new therapeutic interventions? 227
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 227
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 226
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 225
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 223
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 221
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 218
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 215
Docetaxel induced pericardial effusion 214
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 212
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 211
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 205
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 201
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 187
A giant sarcoma of the parotid gland: A case report and review of the literature 178
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 175
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 170
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 169
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 156
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 155
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 154
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 153
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 151
'Old' and 'new' drugs for the treatment of cancer pain 151
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 150
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 149
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 149
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 149
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 147
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 146
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 146
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 145
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 145
Colorectal carcinomas and PTEN/MMAC1 gene mutations 143
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 143
Anestesia e malattie non comuni 143
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 141
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 140
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 139
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 138
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 137
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 137
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 137
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 136
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 135
Atypical chronic head and neck pain: don't forget Eagle's syndrome 135
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 133
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 133
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 132
Biological effects of cabozantinib on bone microenvironment 132
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 131
[Treatment of stage-I seminoma. Critical review] 129
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 126
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 124
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 124
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 124
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 123
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 123
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 123
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 123
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 122
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 122
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 120
Idiosyncratic reaction after oxaliplatin infusion 119
Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study 119
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 119
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 116
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies 114
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 111
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 110
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 107
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 106
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 103
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 103
Totale 17.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 367.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 367.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022999 0 0 0 8 73 10 15 4 42 20 23 804
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.295 52 281 95 171 237 1.039 17 154 23 59 75 92
2024/202518.553 334 274 922 147 171 510 314 63 1.954 1.573 5.751 6.540
2025/202620.637 1.870 776 1.374 2.466 701 1.230 5.302 1.801 1.703 1.872 816 726
2026/20276.108 396 2.273 2.630 809 0 0 0 0 0 0 0 0
Totale 48.804